[Antinuclear antibody (anti-HBc) and liver pathology in acute and chronic virus B hepatitis]

Boll Soc Ital Biol Sper. 1979 Jul 15;55(12):1141-6.
[Article in Italian]

Abstract

HBsAg and anti-HBc, the antibody to core antigen of hepatitis B virion, were titrated by solid phase radioimmunoassay in 40 sera of HBsAg carriers with acute and chronic hepatitis and in 20 healthy subjects carrying anti-HBc alone or associated with anti-HBs. No correlation was found between HBsAg and anti-HBc titers in the single category of patients. In contrast, geometric mean titer of anti-HBc (ranging from 2(14) to 2(15)) of patients with chronic active hepatitis was significantly higher ( p = < 0.01) than that of patients with acute or chronic persistent hepatitis and healthy HBsAg carriers (ranging from 2(9) to 2(14)). Anti-HBc titer of 20 subjects without detectable HBsAg was less than 2(7). These data suggest that in subjects with persistent B virus infection, anti-HBc response is correlated with synthesis of viral genome rather than of surface antigens, so that a much higher titer of anti-HBc was detected only in patients with a more active liver disease.

Publication types

  • English Abstract
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Disease
  • Adult
  • Antibodies, Antinuclear / immunology*
  • Antibodies, Viral / immunology*
  • Chronic Disease
  • Female
  • Hepatitis B / immunology*
  • Hepatitis B Antibodies / immunology*
  • Hepatitis B Core Antigens / immunology
  • Hepatitis B Surface Antigens / immunology*
  • Humans
  • Male
  • Radioimmunoassay

Substances

  • Antibodies, Antinuclear
  • Antibodies, Viral
  • Hepatitis B Antibodies
  • Hepatitis B Core Antigens
  • Hepatitis B Surface Antigens